Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carlota Jordan"'
Autor:
Carolina Garcia-Vidal, Marta Bodro, Laura Morata, Ferran Segui, Josep Mensa, Nacho Grafia, Marta Hernández-Meneses, Juan Ambrosioni, Alex Soriano, Mariana Chumbita, Gemma Sanjuan, Carlos Lopera, Felipe García, José Antonio Martínez, Daiana Agüero, Verónica Rico, Pedro Puerta-Alcalde, Carlota Jordan, Fernanda Meira, Alberto Cózar-Llistó, Rodrigo Alonso-Navarro, Nicole Garcia-Pouton, Pedro Castro, Gerard Dueñas, Celia Cardozo
Publikováno v:
Revista Española de Quimioterapia
Objective. Controversial results on remdesivir efficacy have been reported. We aimed to report our real-life experience with the use of remdesivir from its availability in Spain. Methods. We performed a descriptive study of all patients admitted for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63edc5d4be08dedfc7952b4415708025
https://doi.org/10.37201/req/018.2021
https://doi.org/10.37201/req/018.2021
Autor:
Alex Soriano, Júlia Laporte-Amargós, Mariana Chumbita, Jordi Carratalà, Maria Condom, Carolina Garcia-Vidal, Andrea Ladino, María Suárez-Lledó, Carlota Gudiol, Francesc Marco, Enric Sastre, Ignacio Grafia, Josep Mensa, Alba Bergas, Cristina Helguera, José Antonio Martínez, Adaia Albasanz-Puig, Pedro Castro, Nicole Garcia-Pouton, Xavier Durà, Carlota Jordan, Pedro Puerta-Alcalde
Publikováno v:
Antimicrob Agents Chemother
We analyzed risk factors for mortality in febrile neutropenic patients with bloodstream infections (BSI) presenting with septic shock and assessed the impact of empirical antibiotic regimens. A multicenter retrospective study (2010 to 2019) of two pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2891fcd220fb7651ecb523ddb49ea7ae
https://europepmc.org/articles/PMC8846468/
https://europepmc.org/articles/PMC8846468/
Autor:
Urra, Iratxe Martínez de Narvajas, Cano, Diego Aguiar, Castellano, María Ruiz, Sánchez, David de Haedo, Iborra, Carlota Jordán
Publikováno v:
In Revista clinica espanola November 2023 223 Supplement 2:S92-S93
Autor:
Carlos Chaccour, Aina Casellas, Andres Blanco-Di Matteo, Iñigo Pineda, Alejandro Fernandez-Montero, Paula Ruiz Castillo, Mary-Ann Richardson, Mariano Rodriguez Mateos, Carlota Jordan-Iborra, Joe Brew, Francisco Carmona-Torre, Miriam Giraldez, Ester Laso, Carlota Dobaño, Gemma Moncunill, Jose R Yuste, Jose L Del Pozo, Regina Rabinovich, Verena Schoening, Felix Hammann, Gabriel Reina, Belen Sadaba, Miriam Fernandez-Alonso
Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not readily achievable with currently approved doses. There is limited evidence to support its clinical use in COVID-19 patients. We conducted a Pilot, randomized, double-bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00ab1ec7b3d4e7737bd2e14842682434
https://doi.org/10.21203/rs.3.rs-116547/v1
https://doi.org/10.21203/rs.3.rs-116547/v1
Autor:
Nerea Fernández Ros, Felipe Lucena, Mercedes Iñarrairaegui, Manuel F. Landecho, Patricia Sunsundegui, Carlota Jordán-Iborra, Iñigo Pineda, Jorge Quiroga, Jose Ignacio Herrero
Publikováno v:
BMC Medical Education, Vol 21, Iss 1, Pp 1-5 (2021)
Abstract Background Active learning strategies such as formative assessment through clinical cases may help to get a deeper learning. We have studied the effect of this kind of online formative assessment in pathophysiology teaching. Methods Seven br
Externí odkaz:
https://doaj.org/article/4c95475e8adb4ddcbe169df68b06c14a
Autor:
Carlos Chaccour, Aina Casellas, Andrés Blanco-Di Matteo, Iñigo Pineda, Alejandro Fernandez-Montero, Paula Ruiz-Castillo, Mary-Ann Richardson, Mariano Rodríguez-Mateos, Carlota Jordán-Iborra, Joe Brew, Francisco Carmona-Torre, Miriam Giráldez, Ester Laso, Juan C. Gabaldón-Figueira, Carlota Dobaño, Gemma Moncunill, José R. Yuste, Jose L. Del Pozo, N.Regina Rabinovich, Verena Schöning, Felix Hammann, Gabriel Reina, Belen Sadaba, Mirian Fernández-Alonso
Publikováno v:
EClinicalMedicine, Vol 32, Iss , Pp 100720- (2021)
Background: Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not readily achievable with currently approved doses. There is limited evidence to support its clinical use in COVID-19 patients. We conducted a Pilot, randomize
Externí odkaz:
https://doaj.org/article/3566a7f25e3a4af994af0f2ba472a486